From Casetext: Smarter Legal Research

Solomon Capital, LLC v. Lion Biotechnologies, Inc.

Supreme Court of New York, Appellate Division, First Department
Dec 21, 2021
No. 2021-76319 (N.Y. App. Div. Dec. 21, 2021)

Opinion

2021-76319 Index 651881/16

12-21-2021

Solomon Capital, LLC et al., Plaintiffs-Respondents, v. Lion Biotechnologies, Inc., formerly known as Genesis Biopharma, Inc., Defendant-Appellant. Motion No. 2021-03542 Case No. 2021-00184


Unpublished Opinion

MOTION DECISION

PRESENT: Hon. Cynthia S. Kern, Justice Presiding, Lizbeth González Saliann Scarpulla Manuel J. Mendez, Justices.

Defendant-appellant having moved for leave to appeal to the Court of Appeals from the decision and order of this Court, entered on May 11, 2021 (Appeal No. 13802N), Now, upon reading and filing the papers with respect to the motion, and due deliberation having been had thereon, It is ordered that the motion is denied.


Summaries of

Solomon Capital, LLC v. Lion Biotechnologies, Inc.

Supreme Court of New York, Appellate Division, First Department
Dec 21, 2021
No. 2021-76319 (N.Y. App. Div. Dec. 21, 2021)
Case details for

Solomon Capital, LLC v. Lion Biotechnologies, Inc.

Case Details

Full title:Solomon Capital, LLC et al., Plaintiffs-Respondents, v. Lion…

Court:Supreme Court of New York, Appellate Division, First Department

Date published: Dec 21, 2021

Citations

No. 2021-76319 (N.Y. App. Div. Dec. 21, 2021)